Mattern Wealth Management LLC Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Mattern Wealth Management LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 16.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,235 shares of the healthcare conglomerate’s stock after selling 429 shares during the period. Mattern Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,130,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $32,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth $30,000. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $37,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $543.41 on Tuesday. The company’s fifty day moving average price is $541.04 and its 200 day moving average price is $564.79. The company has a market capitalization of $500.09 billion, a PE ratio of 35.06, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Finally, TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.